The mission of this Program is to prepare a cadre of outstanding cancer epidemiologists through rigorous academic training in research methodology and the epidemiology and biology of cancer, and/or mentored research. Those in the Molecular & Genetic Epidemiology Sub-program receive additional training in the application of molecular genetic techniques to epidemiologic research. A distinguished faculty provides substantial opportunity for research experience. There are three types of trainees: Doctoral Candidates in Epidemiology include both pre-doctoral candidates and those holding a prior doctoral degree (generally clinicians) who undertake 2-3 years of coursework in addition to research; Clinical Researchers include physicians with specialty training in cancer preparing for careers in clinical epidemiology who undertake a one year Master's degree program in methodology followed by a year of research; and Post-doctoral Fellows who hold a prior doctora! degree in Epidemiology or in Biology and undertake mentored research (and coursework if needed) in preparation for an academic career. Trainee positions are generally awarded for 2 or 3 years. The number of trainees requested include 3-4 pre-doctoral and 1-2 post-doctoral Doctoral Candidates; 2 Clinical Researchers; 2 Post-doctoral Fellows with an additional 4 pre-doctoral Doctoral Candidates and 3 Post-doctoral Fellows in the Sub-program for a total of 16 trainees. The Program is based in the Department of Epidemiology of the Harvard School of Public Health. A dedicated molecular epidemiology laboratory is available. This proposal continues a long history of excellence in training in cancer epidemiology at Harvard University.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009001-32
Application #
7271831
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1978-07-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
32
Fiscal Year
2007
Total Cost
$746,027
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Almutairi, Reem D; Muskens, Ivo S; Cote, David J et al. (2018) Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir (Wien) 160:1005-1021
Tabung, Fred K; Liu, Li; Wang, Weike et al. (2018) Association of Dietary Inflammatory Potential With Colorectal Cancer Risk in Men and Women. JAMA Oncol 4:366-373
Senders, Joeky T; Goldhaber, Nicole H; Cote, David J et al. (2018) Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis. J Neurooncol 136:135-145
Floyd, J S; Sitlani, C M; Avery, C L et al. (2018) Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. Pharmacogenomics J 18:127-135
Seyerle, A A; Sitlani, C M; Noordam, R et al. (2018) Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology. Pharmacogenomics J 18:215-226
Busch, Evan L; Don, Prabhani Kuruppumullage; Chu, Haitao et al. (2018) Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. BMC Cancer 18:82
Alotaibi, Nawaf M; Noormohamed, Nadia; Cote, David J et al. (2018) Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis. World Neurosurg 109:487-496.e1
Kamran, Sophia C; Seisen, Thomas; Markt, Sarah C et al. (2018) Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 73:262-270
Busch, Evan L; Whitsel, Eric A; Kroenke, Candyce H et al. (2018) Social relationships, inflammation markers, and breast cancer incidence in the Women's Health Initiative. Breast 39:63-69
Taber, Jennifer M; Dickerman, Barbra A; Okhovat, Jean-Phillip et al. (2018) Skin cancer interventions across the cancer control continuum: Review of technology, environment, and theory. Prev Med 111:451-458

Showing the most recent 10 out of 472 publications